EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?

Mu Guo iD, Xiangbin Yu, Yi Zhun Zhu iD, Yue Yu iD

Molecules · 28.06.2023 · 28 (13) · 5052

DOI: 10.3390/molecules28135052 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 28.06.2023. Verfasst von Mu Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Fujian Medical University, Fuzhou 350122, China. Hauptthemen laut MEDLINE: Thiazoles. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Initiation Fund of Fujian Medical University, Fujian University Industry University Cooperation Project, Fujian University-Industry Cooperation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Imidazothiazole derivatives are becoming increasingly important in therapeutic use due to their outstanding physiological activities. Recently, applying imidazothiazole as the core, researchers have synthesized a series of derivatives with biological effects such as antitumor, anti-infection, anti-inflammatory and antioxidant effects. In this review, we summarize the main pharmacological effects and pharmacological mechanisms of imidazothiazole derivates; the contents summarized herein are intended to advance the research and rational development of imidazothiazole-based drugs in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thiazoles

Stichwörter der Autor:innen

condensed heterocyclic compoundsdruggable candidatesimidazothiazoleslevamisolepharmacological effect

Substanzen

Thiazoles

Autor:innen und Institutionen

  • School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
  • Fujian Center for New Drug Safety Evaluation, Fuzhou 350122, China.
  • School of Pharmacy, Macau University of Science and Technology, Macau 999078, China.

ORCID-Profile: Mu Guo, Yi Zhun Zhu, Yue Yu

Förderung

  • Scientific Research Initiation Fund of Fujian Medical University
  • Fujian University Industry University Cooperation Project
  • Fujian University-Industry Cooperation Project

Zitieren

APA

Guo, M., Yu, X., Zhu, Y. Z., & Yu, Y. (2023). From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?. Molecules, 28(13), 5052. https://doi.org/10.3390/molecules28135052

Vancouver

Guo M, Yu X, Zhu YZ, Yu Y. From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?. Molecules. 2023;28(13):5052. doi:10.3390/molecules28135052

BibTeX
@article{Guo2023,
  author = {Guo, Mu and Yu, Xiangbin and Zhu, Yi Zhun and Yu, Yue},
  title = {From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {13},
  pages = {5052},
  doi = {10.3390/molecules28135052}
}
Kostenlos starten →